In airway smooth muscle (ASM), full and partial muscarinic receptor agonists have been described to have large differences in their ability to induce signal transduction, including Ca 2+ -mobilization. Despite these differences, partial agonists are capable of inducing a submaximal to maximal ASM contraction.
Introduction
Muscarinic receptor stimulation in airway smooth muscle (ASM) results in the activation of phospholipase C, subsequently followed by the production of sn-1,2-diacylglycerol and inositol1,4,5-trisphosphate (IP 3 ) [1] [2] [3] . In response to IP 3 [5] , which is followed by a sustained influx of extracellular Ca 2+ . Smooth muscle contraction is then initiated through the formation of Ca 2+ -calmodulin and subsequent activation of myosin light chain kinase (MLCK), resulting in the phosphorylation of the 20kDa regulatory myosin light chain (MLC 20 ) [6, 7] . Recently, it has been established that contractile stimuli do not exert their effects only by increasing [Ca 2+ ] i , but also by increasing Ca 2+ -sensitivity of the smooth muscle. One of the main regulators involved in 135 this so called Ca 2+ -sensitization is Rho-kinase, which acts through inhibition of myosin light chain phosphatase, resulting in an enhanced MLC 20 phosphorylation and thus an increased level of contraction at a certain [Ca 2+ ] i [8, 9] .
Contraction of ASM preparations by muscarinic receptor agonists is mediated primarily through M 3 -receptor stimulation. Several studies have demonstrated that the involvement of the M 2 -receptor in ASM contraction is minor or negligible [10] [11] [12] . compared concentration response curves (CRCs) for contraction and inositol phosphate accumulation in response to partial and full muscarinic receptor agonists and demonstrated that a strong linear correlation between these two parameters exists. In addition, they showed a considerable reserve of inositol phosphate production for the full agonists methacholine and oxotremorine, but not for the partial agonist McN-A-343 [13] . This transduction reserve is in accordance with studies showing that acetylcholine induces maximal force development by only occupying 4 % of the available muscarinic receptors (large receptor reserve), whereas McN-A-343 has to occupy 80 % of the receptors (low receptor reserve) to achieve the same degree of force [14, 15] . Furthermore, it has been demonstrated that canine tracheal smooth muscle shortens at a significantly faster rate when contracted with acetylcholine than with McN-A-343 [16] . Large differences between full and partial M 3 -agonists regarding Ca 2+ -mobilizing capacity have been described, whereas no differences in dependency on Ca 2+ -influx through voltage-dependent channels appear to be present [17] . To further elucidate mechanisms underlying the differences between full and partial M 3 -receptor agonists, we investigated the contribution of Rho-kinase to ASMcontraction, Ca 2+ -mobilization and Ca
2+
-influx in response to the full muscarinic agonist methacholine and the partial muscarinic agonists pilocarpine and McN-A-343 [18, 19] . We demonstrate that these agonists are differentially dependent on Ca 2+ -mobilization/-influx and Rho-kinase for their contractile effects, and that the functional dependency on Ca 2+ -mobilization and -influx is inversely correlated with Rho-kinase dependency.
Materials and methods

Tissue preparation and organ-culture procedure
Bovine tracheae were obtained from local slaughterhouses and rapidly transported to the laboratory in Krebs-Henseleit (KH) buffer of the following composition (mM): NaCl 117.5, KCl 5.60, MgSO 4 1.18, CaCl 2 2.50, NaH 2 PO 4 1.28, NaHCO 3 25.00 and glucose 5.50, pregassed with 5% CO 2 and 95% O 2 ; pH 7.4. After dissection of the smooth muscle layer and careful removal of mucosa and connective tissue, tracheal smooth muscle strips were prepared while incubated in gassed KH-buffer at room temperature. Care was taken to cut tissue strips with macroscopically identical length (1 cm) and width (2 mm). Tissue strips were washed once in sterile Dulbecco's modification of Eagle's medium (DMEM), supplemented with NaHCO 3 (10 mM), HEPES (20 mM), sodium pyruvate (1 mM), nonessential amino acid mixture (1:100), gentamicin (45 μg/ml), penicillin (100 U/ml), streptomycin (100 μg/ml) and amphotericin B (1.5 μg/ml). Next, tissue strips were transferred into suspension culture flasks (containing 2.5 ml medium per tissue strip) and maintained overnight.
Isometric tension measurements
Tissue strips, collected from suspension culture flasks, were washed with several volumes of KH-buffer pregassed with 5% CO 2 and 95% O 2 , pH 7.4 at 37 ˚C. Subsequently, strips were mounted for isometric recording (Grass force-displacement transducer FT03) in 20 ml water-jacked organ baths, containing KH-buffer at 37 ˚C, continuously gassed with 5% CO 2 and 95% O 2 , pH 7.4. During a 90 min equilibration period, with washouts every 30 min, resting tension was gradually adjusted to 3 g. Subsequently, muscle strips were precontracted with 20 mM and 40 mM isotonic KCl solutions. Following two wash-outs, maximal relaxation was established by the addition of 0.1 μM (-)-isoprenaline. In over 95% of the experiments, no basal myogenic tone was detected. Tension was now re-adjusted to 3 g, immediately followed by two changes of fresh KH-buffer. After another equilibration period of 30 min, cumulative CRCs were constructed to stepwise increasing concentrations of methacholine, pilocarpine or McN-A-343 (1 nM -100 μM). When maximal agonistinduced tension was obtained, the strips were washed several times and maximal relaxation was established using (-)-isoprenaline (10 μM). When used, the Rho-kinase inhibitor Y-27632 (1 μM) was applied to the organ bath 30 min before agonist addition. This concentration has been shown to be effective and selective in smooth muscle [20] [21] [22] . In a separate set of experiments, 100 μM of the alkylating muscarinic receptor antagonist propylbenzilylcholine mustard (PrBCm) was preincubated for 15 minutes, followed by several washouts, prior to the construction of a cumulative CRC of methacholine.
Isolation of bovine tracheal smooth muscle cells
After the removal of mucosa and connective tissue, tracheal smooth muscle was chopped using a McIlwain tissue chopper, two times at the size of 300 μm and three times at 100 μm. Tissue fragments were washed under sterile conditions (three times) and maintained overnight in DMEM supplemented with NaHCO 3 (10 mM), HEPES (20 mM), penicillin (100 U/ml), streptomycin (100 μg/ml) and 10 % fetal bovine serum (FBS) in an incubator shaker (Innova 4000) at 37 ˚C, 55 rpm. was calculated every 0.2 s according to Grynkiewicz [23] . At the end of the experiment, the maximal fluorescence ratio (R max ) was determined after adding 0.01% of Triton-X-100 as a permeabilizing agent. The minimal fluorescence ratio (R min ) was determined by addition of 5 mM EGTA to the permeabilized cells.
Data analysis
All data represent means ± S.E.M. from n separate experiments. CRCs of contractile responses were analyzed by measuring myogenic tension. No corrections were made for basal tone. Maximal tension (E max ) and pEC 50 were calculated from the CRCs. Curves were fitted using the logistic 4-parameter model (Sigmaplot 9.0, SPSS Inc. -mobilization and -influx were expressed as a percentage of the maximal methacholine-induced Ca 2+ -mobilization. Statistical significance of differences between data was determined using the two-tailed Student's t-test for paired observations or one-way analysis of variance, where appropriate. Differences were considered to be statistically significant when P < 0.05.
Materials
Dulbecco's modification of Eagle's Medium (DMEM) and methacholine hydrochloride were obtained from ICN Biomedicals (Costa Mesa, CA, U.S.A.). Foetal bovine serum, NaHCO 3 solution (7.5%), HEPES solution (1 M), sodium pyruvate solution (100 mM), non-essential amino acid mixture, gentamycin solution (10 mg/ml), penicillin/streptomycin solution (5000 U/ml; 5000 μg/ml) and amphotericin B solution (250 μg/ml) (Fungizone) were obtained from Gibco BRL Life Technologies (Paisley, U.K.). Dithiothreitol (DTT), soybean trypsin inhibitor, Fura-2/AM, pilocarpine hydrochloride and (-)-isoprenaline 
Results
Effects of Rho-kinase-inhibition on methacholine-, pilocarpine-and McN-A-343-induced airway smooth muscle contraction
In bovine tracheal smooth muscle strip preparations, pilocarpine and McN-A-343 reached up to 87 % and 84 %, respectively, of the maximal contraction (E max ) induced by methacholine, indicating that both pilocarpine and McN-A-343 are partial agonists (Fig. 1 , Table 1 ). To determine the contribution of Rho-kinase, we used the selective Rho-kinase inhibitor Y-27632 (1 μM). With methacholine, no effect of Rho-kinase inhibition was observed on E max , but a significant decrease in potency (pEC 50 ) was observed. Interestingly, treatment with Y-27632 significantly decreased E max of pilocarpine and McN-A-343 by 23,4 ± 2.8 % and 50,4 ± 7.9 %, respectively, and also significantly decreased potency (Fig. 1, Table 1 ). Remarkably, the effect of Y-27632 in decreasing pEC 50 -values diminished in the order methacholine>pilocarpine>McN-A-343. Effects of Rho-kinase-inhibition on intracellular Ca 2+ homeostasis in response to methacholine, pilocarpine and McN-A-343 Ca 2+ -mobilization and -influx were determined in response to several concentrations of methacholine, pilocarpine and McN-A-343 (Fig. 2) . Both mobilization and influx were calculated as a percentage of the maximal methacholine-induced Ca 2+ -mobilization, which amounted to 349.7 ± 53.9 nM Ca 2+ . Mobilization induced by pilocarpine and McN-A-343 (Fig. 2a) was significantly lower as compared to that induced by methacholine and reached up to only 10.0 ± 0.8 % and 5.8 ± 1.6 %, respectively (P<0.001, both). Ca 2+ -influx in response to these agonists was also significantly lower (8.9 ± 1.1 % and 7.1 ± 1.7 %, respectively; Figure 2b ) as compared to methacholine-induced influx (13.9 ± 0.5 %; P<0.01, both). Next, to determine whether the effects of Rho-kinase-inhibition on contraction (Fig. 1) could be linked to effects on Ca 2+ -mobilization or -influx, we measured Ca 
Effects of muscarinic receptor alkylation on the Rho-kinase dependency of the methacholine-induced contraction
To determine whether differences in receptor reserve could be responsible for the difference in Rho-kinase dependency of the contraction induced by full and partial agonists, we removed receptor reserve of the full agonist methacholine by using the alkylating agent propylbenzilylcholine mustard (PrBCm). In contrast to methacholine-induced contraction of untreated strips (Fig. 1a) , maximal methacholine-induced contraction was Rho-kinase dependent after treatment with PrBCm (24.8 ± 9.2 % inhibition of E max in the presence of Y-27632; P<0.05; Fig. 4 ). These results suggest that the contribution of Rho-kinase to muscarinic agonist-induced contraction is dependent on receptor/transduction reserve. Interestingly, after PrBCm-pretreatment, the reduction of the pEC 50 value of methacholine by Y-27632 was of similar magnitude as in non-alkylated preparations (Table 1) .
Relationship between Rho-kinase dependency and Ca 2+ -mobilization and -influx
For several agonist concentrations we have plotted the effectiveness of Y-27632 in decreasing contraction (% inhibition) against the induced Ca 2+ -mobilization and the Ca 2+ -influx (Fig. 5 ). An inverse relationship between Rho-kinase-dependency and Ca 2+ -mobilization ( Fig. 5a ) as well as Ca 2+ -influx (Fig. 5b) was found. 
Discussion
In the present study, we demonstrate that full and partial muscarinic agonists are differentially dependent on Rho-kinase and Ca 2+ -mobilization for their contractile effects.
Moreover, we show that there is an inverse (exponential) relationship between the Rhokinase-dependency of the contraction and the Ca 2+ -mobilization as well as the Ca 2+ -influx induced by different concentrations of the agonists. These findings correspond to observations in canine tracheal smooth muscle using acetylcholine and McN-A-343, indicating that differences in Ca 2+ -kinetics possibly are a consequence of differences in potency of muscarinic agonists to activate the same subcellular pathways, rather than from the activation of distinct subcellular mechanisms [24] . A receptor-dependent role of Rho-kinase in agonist-induced ASM contraction appears to exist. Both in guinea pig [25] and human [26] ASM it was found that growth factors, which are coupled to receptor tyrosine kinases, induce contractions which are fully Rho-kinase dependent, whereas contractions elicited by histamine, which are mediated through G q/11 -coupled H 1 receptors, are not [27, 28] . In addition, potency and maximal contraction induced by PGF 2α are governed by Rho-kinase activity in guinea pig tracheal smooth muscle to an important extent, whereas histamine-induced contractions are not [29] . The agonists used in the present study all function through activation of the M 3 -receptor in order to induce ASM contraction. The observed differential involvement of Rho-kinase by partial and full agonists therefore implies that there is not only a receptor-dependent, but also an agonist-dependent role for the participation of Rho-kinase in ASM contraction. Rho-kinase inhibition resulted in a decrease in potency of methacholine, pilocarpine and McN-A-343, whereas E max was affected only for pilocarpine and McN-A-343. Remarkably, the strongest decrease in potency was observed for methacholine and the smallest for McN-A-343; in contrast to the effects on E max which were absent for methacholine and most pronounced for McN-A-343. This indicates that methacholine is only dependent on Rhokinase for its contractile effects in the lower concentration range, without requiring Rhokinase to achieve its maximal contractile response. In bovine tracheal smooth muscle there is a considerable reserve of inositol phosphate production (transduction reserve) for methacholine but not for McN-A-343 [30] . If the maximally stimulated M 3 -receptor generates more Rho-kinase activity than 'required' for maximal contractile effect, inhibition of this signal transduction will affect the potency, not the efficacy, of the agonist. In other words, methacholine induces the largest IP 3 -dependent Ca 2+ -mobilization andinflux , which is probably sufficient to achieve maximal contraction independent of Rhokinase-mediated Ca 2+ -sensitization. In contrast, very low levels of Ca
2+
-mobilization are observed in response to pilocarpine and McN-A-343, presumably as a consequence of a small and neglectable transduction reserve, respectively, [31] , and therefore these agonists do rely on Rho-kinase for their maximal contractile response. Also, fully in line with this interpretation, maximal methacholine-induced contraction becomes Rho-kinase dependent after pretreatment with the irreversible muscarinic receptor antagonist PrBCm, demonstrating that the contribution of Rho-kinase to muscarinic agonist-induced contraction is dependent on transductional reserve. Remarkably, in the presence of Y-27632 a similar decrease of potency is observed in PrBCm-treated strips as in untreated strips. An additional explanation for the differences between full and partial agonists in the modulation of the maximal contraction, might therefore be that partial agonists have different relative activation profiles for G q -and G i/o -proteins as compared to full agonists, as demonstrated in Chinese hamster ovary cells [32] . The inverse relationship between Rho-kinase dependency and both Ca 2+ -mobilization and Ca 2+ -influx, as shown in Figure 5 , might suggest that Y-27632 is capable of reducing these Ca 2+ -responses. However, we demonstrate that Y-27632 does not inhibit Ca 2+ -mobilization or Ca
-influx for all three agonists at their maximal concentration. In addition, no effect of Rho-kinase inhibition was observed when a submaximal concentration of methacholine (1 μM) was applied (data not shown), corresponding to findings in guinea pig trachealis, which showed no effects of Y-27632 (1-10 μM) on methacholine (1μM)-induced Ca 2+ -mobilization [33] . This strongly suggests that the effects of Rho-kinase-inhibition are on the level of Ca 2+ -sensitization rather than on Ca 2+ -mobilization or -influx.
In conclusion, this study shows that full and partial muscarinic receptor agonists are differentially dependent on Rho-kinase for their contractile effects, indicating an agonist-dependent role for Rho-kinase in ASM contraction. Furthermore, we demonstrate that there is an inverse relationship between both Ca 2+ -mobilization and Ca 2+ -influx and the functional Rho-kinase dependency, presumably as a consequence of differences in transduction reserve between full and partial M 3 -receptor agonists. Moreover, Ca 2+ -mobilization and -influx in response to M 3 -receptor stimulation seem to be independent of Rho-kinase, suggesting that differences in functional Rho-kinase dependency are on the level of Ca 2+ -sensitization rather than on Ca 2+ -mobilization or -influx.
